Early test of new pill for chronic pain shows promise
NCT ID NCT06810245
Summary
This early-stage study tested a new oral medication called PIPE-791 to see if it is safe and can help reduce pain. It involved 43 adults with long-term pain from knee arthritis or low back pain. Participants tried both the drug and a placebo for four weeks each to compare their effects on pain levels and safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LOW BACK PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Altoona Center of Clinical Research
Duncansville, Pennsylvania, 16635, United States
-
Arizona Research Center
Phoenix, Arizona, 85053, United States
-
Drug Studies America
Marietta, Georgia, 30060, United States
-
Drug Trials America
Hartsdale, New York, 10530, United States
-
JBR Clinical Research
Salt Lake City, Utah, 84107, United States
Conditions
Explore the condition pages connected to this study.